It is too soon to tell whether the shots have a broad beneficial effect on patients with continuing issues, but scientists are intrigued and beginning to study the phenomenon. Judy Dodd began struggling with long Covid symptoms last spring — shortness of breath, headaches, exhaustion. Then she got the vaccine. …
Read More »
Listen to This Article To hear more audio stories from publishers like The New York Times, download Audm for iPhone or Android. Faced with the daunting task of parceling out a limited supply of coronavirus vaccines, Trump administration officials came up with a seemingly simple formula last year to streamline …
Read More »
It did not take long for Keith Reed, a deputy health commissioner in Oklahoma, to spot a big logistical problem with the state’s vaccination rollout. Week after week, Oklahoma was allocating thousands of precious doses to a federal program for nursing home patients that was not using them all. In …
Read More »
The company will ask federal regulators to increase the amount of coronavirus vaccine it can put in each vial by as much as 50 percent, potentially bolstering availability quickly. Moderna is asking United States regulators to approve what it says could be a remarkably simple proposal to speed up the …
Read More »
A pharmacist who was arrested on charges that he intentionally sabotaged more than 500 doses of the Covid-19 vaccine at a Wisconsin hospital was “an admitted conspiracy theorist” who believed the vaccine could harm people and “change their DNA,” according to the police in Grafton, Wis., where the man was …
Read More »
The company could provide at least tens of millions of additional doses of a coronavirus vaccine under an agreement that would give it better access to the supplies it needs to expand manufacturing. The Trump administration and Pfizer are close to a deal under which the pharmaceutical company would bolster …
Read More »
The company could provide at least tens of millions of additional doses of a coronavirus vaccine under an agreement that would give it better access to the supplies it needs to expand manufacturing. The Trump administration and Pfizer are close to a deal under which the pharmaceutical company would bolster …
Read More »